The potential mechanism of Saikosaponin D against luminal A breast cancer based on bioinformatical analysis, molecular docking and in vitro studies
Abstract Background Saikosaponin D (SSD) has been shown to have the strongest anti-tumor activity. This study aimed to explore the effects and potential molecular mechanism of Saikosaponin D (SSD) against estrogen receptor-positive breast cancer. Methods MCF-7 and T-47D cell lines were treated with...
Saved in:
| Main Authors: | Lichang Yang, Ru Chang, Jianzhen Pan, Shan Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00510-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effect of saikosaponin D against gestational diabetes mellitus via regulating TLR4/MyD88/NF-κB and MAPK signaling pathway
by: Lu-Lu Wang, et al.
Published: (2025-07-01) -
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
by: Zeynep Madak‐Erdogan, et al.
Published: (2013-06-01) -
Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
by: A. I. Stukan, et al.
Published: (2022-12-01) -
Recent advances of G protein‐coupled estrogen receptor 1 in the metabolism of bone
by: FENG Yuan, et al.
Published: (2023-06-01) -
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results
by: Erika P. Hamilton, et al.
Published: (2025-07-01)